Latest News

Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved patient outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient?s HPV status provides an effective indicator of improved patient outcome, according to research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Typically disregarded brain lesions may warn of heightened stroke risk

  • Nanomedicine in the fight against thrombotic diseases

  • Increased risk of complications, death during delivery for women with epilepsy

  • Cognitive behavioral therapy for insomnia with psychiatric, medical conditions

  • Reducing stroke damage may be next for optical coherence tomography technology widely used in vision healthcare

  • Restraint, confinement still an everyday practice in mental health settings

  • Age-related cognitive decline tied to immune-system molecule

  • New study again shows: More strokes with intracranial stents

  • People over 65 with traumatic brain injuries hospitalized four times as often as younger people

  • Uncovering the mechanism of our oldest anesthetic

  •